Firmagon FDA Approved Drugs
FIRMAGON [Degarelix AcetateC82H103ClN18O16C2H4O2H2O]
RX
- eq 120mg base/vial (subcutaneous powder)
eq 80mg base/vial (subcutaneous powder)
FerringDec 24, 2008
- Gnrh antagonist indicated for treatment of patients with advanced prostate cancer.
- Method of treating prostate cancer.
- Treatment of advanced prostate cancer with a reduced likelihood of causing a gonadotrophin releasing hormone agonist side-effect.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.